© 2024 CSRXP- All Rights Reserved
[Forbes.com] The Sovaldi Tax: Gilead Can’t Justify The Price It’s Asking For Hepatitis C Therapy
Jun 18, 2014
A cure for hepatitis C is within reach for 170 million people around the world — thanks to the charitable efforts of poor and sick Americans who are picking up the tab by paying outrageous prices for their own treatment. It’s like Robin Hood in reverse.
This is what happens when a pill is priced at $1,000 a day in the U.S., and an entire treatment regimen of 84 of those pills costs just $900 in Egypt. Exact same medicine, completely different pricing.
[button title=”Read More” link=”http://www.forbes.com/sites/theapothecary/2014/06/17/the-sovaldi-tax-gilead-cant-justify-the-price-its-asking-americans-to-pay/” target=”_blank” size=”” color=”” class=””]